Showing results (1481-1490 of 1,529) with videos related to
Sort By:
Pageof 153
Journal of Medicinal Chemistry|January 19, 2008
Discovery of potent and selective dipeptidyl peptidase IV inhibitors derived from beta-aminoamides bearing subsituted triazolopiperazinesDooseop Kim, Jennifer E Kowalchick, Linda L Brockunier, et al.Pediatrics|April 20, 2023
Improving the Quality of Written Discharge Instructions: A Multisite Collaborative ProjectArti D Desai, Anagha Tolpadi, Layla Parast, et al.Journal of Medicinal Chemistry|January 7, 2005
(2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetesDooseop Kim, Liping Wang, Maria Beconi, et al.Virchows Archiv : an International Journal of Pathology|February 29, 2012
Decentral gene expression analysis for ER+/Her2- breast cancer: results of a proficiency testing program for the EndoPredict assayCarsten Denkert, Ralf Kronenwett, Werner Schlake, et al.Sensors (Basel, Switzerland)|June 20, 2019
Moving towards a Network of Autonomous UAS Atmospheric Profiling Stations for Observations in the Earth's Lower Atmosphere: The 3D Mesonet ConceptPhillip B Chilson, Tyler M Bell, Keith A Brewster, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2020
A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer TrialThomas Karn, Tobias Meissner, Karsten E Weber, et al.JAMA Neurology|February 7, 2022
Comparison of Mobile Stroke Unit With Usual Care for Acute Ischemic Stroke Management: A Systematic Review and Meta-analysisGuillaume Turc, Melika Hadziahmetovic, Silke Walter, et al.International Journal of Biological Sciences|October 20, 2022
Serological responses to human virome define clinical outcomes of Italian patients infected with SARS-CoV-2Limin Wang, Julián Candia, Lichun Ma, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2011
A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factorsMartin Filipits, Margaretha Rudas, Raimund Jakesz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Gene Expression-Based Prediction of Neoadjuvant Chemotherapy Response in Early Breast Cancer: Results of the Prospective Multicenter EXPRESSION TrialKarolina Edlund, Katrin Madjar, Antje Lebrecht, et al.Pageof 153